Tricyclic antidepressant toxicity

Overview


Plain-Language Overview

Tricyclic antidepressant toxicity occurs when someone takes too much of a certain type of medication used to treat depression and other mental health conditions. These drugs affect the nervous system and can cause serious problems with the heart and brain. Symptoms often include confusion, drowsiness, and a fast or irregular heartbeat. The toxicity can also lead to dangerous breathing difficulties and seizures. This condition is a medical emergency because it can quickly worsen and affect vital body functions.

Clinical Definition

Tricyclic antidepressant toxicity is a clinical syndrome caused by overdose or accumulation of tricyclic antidepressants, which block norepinephrine and serotonin reuptake and have anticholinergic, quinidine-like sodium channel blocking, and alpha-1 adrenergic blocking effects. The core pathology involves cardiac conduction abnormalities (e.g., prolonged QRS), central nervous system depression, and anticholinergic toxicity. It commonly results from intentional or accidental overdose. The major clinical significance lies in its potential to cause life-threatening arrhythmias, seizures, and hypotension. Early recognition and management are critical to prevent fatal outcomes.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses


Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

Analytics Disclosure: If you allow analytics cookies, Doctogenic uses Google Analytics, Microsoft Application Insights, and Microsoft Clarity to understand site usage, diagnose issues, review heatmaps and session replay recordings, and improve the service on pages where those tools are enabled. Clarity is not enabled on account, purchase, billing, checkout, Stripe-related, or admin pages. You can change this choice through Cookie preferences.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.